arrow
C

Clara Grazia Chisari

university of catania
H指数:29
被引数:2,602

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AI-based predictive biomarkers for chronic neurological diseases: the rAIdD prospective; multicenter; observational study protocol

基于AI的慢性神经系统疾病预测性生物标志物:rAIdD前瞻性、多中心、观察性研究方案

2026-07-200
OA
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)

评估接受不同治疗方案序列治疗的视神经脊髓炎患者队列中长期严重不良事件风险的概况:意大利视神经脊髓炎及相关疾病登记研究(I-MS&RD)(ProSA研究)结果

2026-07-040
PRE
Impact of cladribine tablets on PROs in patients with MS: insights from the 1st interim analysis of the CLADFIT-MS study

克立屈滨片对多发性硬化患者结局的影响:来自CLADFIT-MS研究首次中期分析的见解

2026-04-110
OA
Assessing validity and reliability of the Benefit Finding Scale in Italian people with multiple sclerosis and their caregivers

评估意大利多发性硬化症患者及其护理人员的收益发现量表的有效性和可靠性

2026-01-270
OAAI
Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study)

利妥昔单抗在高活性疾病修饰疗法治疗后的复发型多发性硬化中的有效性(RENEGADE研究)

2025-12-240
OAAI
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis

一年治疗反应预测复发缓解型多发性硬化患者后续5年的疾病进程

2025-02-010
OAAI
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy

小儿,成人和迟发性多发性硬化症: 认知表型和灰质萎缩

2025-01-240
OA
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

那他珠单抗治疗继发性进行性多发性硬化的长期疗效: 一项倾向匹配研究

2024-07-011
OAAI
Optic Nerve Head and Retinal Changes in Idiopathic Intracranial Hypertension: Correlation with Short-Term Cerebrospinal Fluid Pressure Monitoring

特发性颅内高压的视神经乳头和视网膜变化: 与短期脑脊液压力监测的相关性

2024-01-182
OA
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
2023-10-019
OAAI
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

整个怀孕期间暴露于那他珠单抗: 在意大利多发性硬化症女性队列中的有效性和安全性

2022-09-3015
PRE
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register

向继发性进行性多发性硬化症临床过渡的有效定义: 来自意大利MS注册中心的一项研究

2022-08-157
PRE